Baxter Bioscience, Biomedical Research Centre, Uferstr. 15, A-2304 Orth an der Donau, Austria. brian
Vaccine. 2010 Dec 16;29(2):166-73. doi: 10.1016/j.vaccine.2010.10.065. Epub 2010 Nov 4.
In the present study the homologous and heterologous type and subtype specific cellular immune response induced by a wild type inactivated whole virus H5N1 Influenza (A/Vietnam/1203/2004) vaccine was evaluated. Two immunizations with the Vero cell derived H5N1 influenza vaccine on Day 0 and Day 21 induced significant H5N1 vaccine specific and H5 haemagglutinin specific clade and cross-clade reactive CD4(+) T cell responses, which were maintained at significant levels for at least 6 months. The H5N1 vaccine specific response cross-reacted with the H1N1, but not with H3N2 or B seasonal Influenza strains. The vaccine significantly increased the number of H5N1 specific and H5 haemagglutinin specific memory B cells, 6 months after the primary immunization, however no H1N1 specific cross-reactivity was observed. Importantly, the inactivated whole virus H5N1 vaccine was just as effective in inducing CD4(+) T cell and memory B cell response in the elderly (60 years or over) as in the adult population (18-59 years).
在本研究中,评估了一种野生型灭活全病毒 H5N1 流感(A/Vietnam/1203/2004)疫苗诱导的同源和异源型及亚型特异性细胞免疫应答。在第 0 天和第 21 天两次接种 Vero 细胞来源的 H5N1 流感疫苗可诱导出显著的 H5N1 疫苗特异性和 H5 血凝素特异性分支和交叉分支反应性 CD4(+)T 细胞应答,至少在 6 个月内保持在显著水平。H5N1 疫苗特异性应答与 H1N1 交叉反应,但与 H3N2 或 B 季节性流感株无交叉反应。疫苗接种后 6 个月,可显著增加 H5N1 特异性和 H5 血凝素特异性记忆 B 细胞的数量,但未观察到 H1N1 特异性交叉反应。重要的是,灭活全病毒 H5N1 疫苗在老年人(60 岁或以上)和成年人(18-59 岁)中诱导 CD4(+)T 细胞和记忆 B 细胞应答的效果相同。